Study: Pharmaceutical Companies Face a Myriad of Barriers in New Orleans Market

NASHVILLE, Dec 08, 2011 (BUSINESS WIRE) -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that pharmaceutical companies face an unfavorable market place in New Orleans. There are a myriad of barriers to market access, according to the recently published New Orleans Market Overview.

New Orleans continues to have a physician shortage which can limit the number of prescriptions written. The market's academic medical center, Louisiana State University School of Medicine, has strong conflict-of-interest policies for its physicians who deal with the pharmaceutical industry which creates a higher barrier to entry with these physicians, according to the report.

"New Orleans has a large uninsured population of about 19 percent of the market," said HealthLeaders-InterStudy Analyst Jenny Kerr. "This will continue to present challenges to pharmaceutical sales." On the bright side, a new step-therapy bill passed in the Louisiana 2011 legislative session will allow physicians to override step-therapy requirements in some cases, which could benefit pharma sales, according to the report.

An abstract of the report is available here: http://hl-isy.com/Products-and-Services/Market-Overviews/Southeast/2011/New-Orleans-Market-Overview

SOURCE: HealthLeaders-InterStudy Kristi Guillemette, 781-993-2618 kguillemette@hl-isy.com or Decision Resources Group Elizabeth Marshall, 781-993-2563 emarshall@dresources.com (C)Business Wire 2011 Reprinted with permission.

Tags:

Bookmark:

Digg

Facebook

Technorati

Newsvine

Google

Related: